Find a Clinical Trial | Tufts Medicine

Filter

Showing 51 - 56 out of 56

PreDICT

Predicting the Success of Dry Eye Disease Treatment Using Hyperosmolarity Drops

Dry eyes

All genders

18+

Recruiting now

Department of Ophthalmology

Learn more

ON-TRK

Prospective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

Solid tumors

All genders

No minimum age

Recruiting now

Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center

Learn more

R33

Prospective study to validate the imaging biomarker for neuropathic corneal pain

Dry eyes

All genders

18+

Recruiting now

Department of Ophthalmology

Learn more

S1925

S1925: Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

Chronic lymphocytic leukemia (CLL), Lymphoma

All genders

18+

Recruiting now

Department of Medicine, Division of Hematology/Oncology, Cancer Center

Learn more

In-Office Pain Tests for Neuropathic Corneal Pain

The Utility of In-Office Pain Tests to Distinguish Patients with Neuropathic Corneal Pain from Patients with Dry Eye Disease

Corneal pain, Dry eyes

All genders

18+

Recruiting now

Department of Ophthalmology

Learn more

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)

XPORT-EC-042 (GOG-3083): A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Endometrial cancer

All genders

18+

Recruiting now

Department of Medicine, Division of Hematology/Oncology, Cancer Center

Learn more